Page last updated: 2024-12-07

inositol-3,4,5,6-tetrakisphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Inositol-3,4,5,6-tetrakisphosphate (InsP4) is a signaling molecule involved in a variety of cellular processes, including calcium signaling, membrane trafficking, and cell growth. It is a phosphorylated derivative of inositol, a sugar alcohol that is a component of cell membranes. InsP4 is synthesized from inositol-1,4,5-trisphosphate (InsP3) by the action of the enzyme inositol polyphosphate 5-kinase. InsP4 has been shown to have a number of effects on cells, including stimulating the release of calcium from intracellular stores, regulating the activity of protein kinases, and modulating the activity of ion channels. InsP4 is also involved in the regulation of gene expression and cell proliferation. The importance of InsP4 in cellular signaling has led to a great deal of research into its role in various diseases, including cancer and neurodegenerative disorders. The study of InsP4 may provide insights into the development of new therapeutic agents for these diseases.'

inositol-3,4,5,6-tetrakisphosphate: for cpd without numerical locants of phosphate groups, index INOSITOL PHOSPHATES [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1D-myo-inositol 3,4,5,6-tetrakisphosphate : A myo-inositol tetrakisphosphate having the four phosphate groups placed at the 3-, 4-, 5- and 6-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID121920
CHEMBL ID23050
CHEBI ID15844
SCHEMBL ID544343
MeSH IDM0217730

Synonyms (34)

Synonym
bdbm50075650
myo-inositol-3,4,5,6-tetrakisphosphate
ins-3,4,5,6-p4
112791-61-4
CHEBI:15844 ,
1l-myo-inositol 1,4,5,6-tetrakis(dihydrogen phosphate)
inositol-3,4,5,6-tetraphosphate
d-myo-inositol 3,4,5,6-tetrakisphosphate
inositol 3,4,5,6-tetrakisphosphate
C04520
1d-myo-inositol 3,4,5,6-tetrakisphosphate
ins(3,4,5,6)p4
CHEMBL23050 ,
myo-inositol, 1,4,5,6-tetrakis(dihydrogen phosphate)
inositol-1,4,5,6-tetrakisphosphate
inositol-3,4,5,6-tetrakisphosphate
myo-inositol-1,4,5,6-tetrakisphosphate
ins-1,4,5,6-p4
inositol-1,4,5,6-tetraphosphate
d-myo-inositol, 3,4,5,6-tetrakis(dihydrogen phosphate)
myo inositol 3,4,5,6 tetrakisphosphate
4my ,
gtpl4224
[(1r,2s,3s,4r,5s,6r)-3,4-dihydroxy-2,5,6-triphosphonooxycyclohexyl] dihydrogen phosphate
SCHEMBL544343
{[(1r,2s,3r,4s,5s,6r)-3,4-dihydroxy-2,5,6-tris(phosphonooxy)cyclohexyl]oxy}phosphonic acid
MRVYFOANPDTYBY-UZAAGFTCSA-N
(1s,2r,3r,4s,5r,6s)-5,6-dihydroxycyclohexane-1,2,3,4-tetrayl tetrakis(dihydrogen phosphate)
(1s,2r,3r,4s,5r,6s)-5,6-dihydroxycyclohexane-1,2,3,4-tetrayl tetrakis[dihydrogen (phosphate)]
d-myo-inositol 3,4,5,6-tetraphosphate
DTXSID80920893
109837-24-3
Q27078077
[(1s,2s,3r,4s,5r,6r)-2,3-dihydroxy-4,5,6-triphosphonooxycyclohexyl] dihydrogen phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
myo-inositol tetrakisphosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Inositol Metabolism2226
Inositol Phosphate Metabolism1423

Bioassays (1)

Assay IDTitleYearJournalArticle
AID93054Inhibition of Ins(1,3,4,5)P4-PtdIns(3,4,5)P3-specific receptor from Pig cerebellum membrane1999Journal of medicinal chemistry, Apr-08, Volume: 42, Issue:7
Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5, 6-trisphosphate: aspects of their structure-activity relationship to biologically active inositol phosphates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (8.82)18.7374
1990's35 (51.47)18.2507
2000's19 (27.94)29.6817
2010's8 (11.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.79 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]